Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis

摘要

Methods for the use of NSAIs in combination with anecortave acetate are disclosed for preventing and treating pathologic ocular angiogenesis and associated edema, retinal edema, PPDR or NPDR.